Here is a nice review of treatment of older patients with hematologic malignancies – there is a very nice section on the treatment and data re: DLBCL treatment and CNS prophylaxis.
Casgevy is the first CRISPR-based medicine to be approved for use in the United States for sickle cell disease and beta-thalassemia.
Intrinsically safe designs and a staged transparent development process will be essential
Cheryl Schwartz discusses Takeda’s report that calls for enhanced health equity and timely diagnosis for rare disease patients
Newsweek is partnering with Statista for the inaugural ranking of the World’s Best Digital Health Companies. The list includes 400 companies based in 35 countries
Few areas in cardiology are as active as development and implementation of medical therapies for heart failure, and few people are as familiar with that…
Be part of a global volunteer community engaged in health evidence work
Dr. B S Ajaikumar – Celebrated Oncologist & Executive Chairman HCG Cancer Centres. An Indian oncologist and entrepreneur. He is the founder and executive chairman…
Behaviour change theory and Motivational Interviewing (MI) principles are often an area cited by healthcare professionals as something they would like more training on. The…
People are warned to look out for early symptoms like a high temperature, cough and red eyes.
